Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Galm

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Epigenetics|October 30, 2007
EHA scientific workshop report: the role of epigenetics in hematological malignanciesEdgar Jost, Oliver Galm
International Journal of Hematology|October 16, 2004
Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignanciesOliver Galm, Manel Esteller
Methods in Molecular Medicine|June 22, 2005
Methylation-specific polymerase chain reactionOliver Galm, James G Herman
Cancer Letters|October 3, 2002
Synergism between rViscumin and cisplatin is not dependent on ERCC-1 expressionOliver Galm, Ursula Fabry, Thomas Efferth, et al.
Medizinische Klinik (Munich, Germany : 1983)|June 18, 2003
[HbH disease--a rare differential diagnosis in a patient with anemia and abdominal pain]Ursula Fabry, Elisabeth Kohne, Oliver Galm, et al.
Blood Reviews|January 24, 2006
The fundamental role of epigenetics in hematopoietic malignanciesOliver Galm, James G Herman, Stephen B Baylin
Leukemia & Lymphoma|April 7, 2009
CpG island methylation patterns in chronic lymphocytic leukemiaBarbara Seeliger, Stefan Wilop, Rainhardt Osieka, et al.
Leukemia & Lymphoma|November 21, 2008
Rituximab-associated changes in platelet count in patients with non-Hodgkin lymphomaStefan Wilop, Oliver Galm, Reyad Dada, et al.
Blood|November 29, 2002
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myelomaOliver Galm, Hirohide Yoshikawa, Manel Esteller, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 11, 2010
[Anemia and severe thrombocytopenia in celiac disease]Maximilian Hatting, Oliver Galm, Martin Meyer, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Epigenetics|October 30, 2007
EHA scientific workshop report: the role of epigenetics in hematological malignanciesEdgar Jost, Oliver Galm
International Journal of Hematology|October 16, 2004
Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignanciesOliver Galm, Manel Esteller
Methods in Molecular Medicine|June 22, 2005
Methylation-specific polymerase chain reactionOliver Galm, James G Herman
Cancer Letters|October 3, 2002
Synergism between rViscumin and cisplatin is not dependent on ERCC-1 expressionOliver Galm, Ursula Fabry, Thomas Efferth, et al.
Medizinische Klinik (Munich, Germany : 1983)|June 18, 2003
[HbH disease--a rare differential diagnosis in a patient with anemia and abdominal pain]Ursula Fabry, Elisabeth Kohne, Oliver Galm, et al.
Blood Reviews|January 24, 2006
The fundamental role of epigenetics in hematopoietic malignanciesOliver Galm, James G Herman, Stephen B Baylin
Leukemia & Lymphoma|April 7, 2009
CpG island methylation patterns in chronic lymphocytic leukemiaBarbara Seeliger, Stefan Wilop, Rainhardt Osieka, et al.
Leukemia & Lymphoma|November 21, 2008
Rituximab-associated changes in platelet count in patients with non-Hodgkin lymphomaStefan Wilop, Oliver Galm, Reyad Dada, et al.
Blood|November 29, 2002
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myelomaOliver Galm, Hirohide Yoshikawa, Manel Esteller, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 11, 2010
[Anemia and severe thrombocytopenia in celiac disease]Maximilian Hatting, Oliver Galm, Martin Meyer, et al.
Pageof 4